Advertisement
Screener

iRhythm Holdings, Inc. (IRTC) EBITDA

iRhythm Holdings, Inc. (IRTC) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $2.66M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$11.19M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $7.49M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$3.23M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$2.66M(m)(m)(m)1.19%$13.56M*$51.08M*(m)(m)$131.66M$0.00
2026-03-31Reported-$11.19M(m)(m)(m)-5.61%$6.91M-$26.17M(m)(m)$135.88M$500.00K
2025-12-31Reported$7.49M(m)(m)(m)3.58%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$3.23M(m)(m)(m)-1.67%$14.83M*$34.88M*(m)(m)$124.22M$24.00K
2025-06-30Reported-$13.61M(m)(m)(m)-7.29%$10.37M*$27.66M*(m)(m)$126.38M-$183.00K
2025-03-31Reported-$27.36M(m)(m)(m)-17.24%$9.42M-$7.89M(m)(m)$119.96M$665.00K
2024-12-31Reported$1.22M(m)(m)(m)0.74%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$45.2M(m)(m)(m)-30.64%$8.83M*$24.35M*(m)(m)$103.38M$188.00K
2024-06-30Reported-$17.78M(m)(m)(m)-12.01%$8.49M*$11.84M*(m)$19.69M$106.76M$194.00K
2024-03-31Reported-$33.04M(m)(m)(m)-25.04%$9.78M-$52.03M(m)$16.99M$108.66M$32.00K
2023-12-31Reported-$34.28M(m)(m)(m)-25.87%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$23.5M(m)(m)(m)-18.86%$9.09M*$1.20M*(m)$16.31M$93.77M$195.00K
2023-06-30Reported-$15.07M(m)(m)(m)-12.14%$9.40M*-$4.57M*(m)$13.68M$91.42M$213.00K
2023-03-31Reported-$35.9M(m)(m)(m)-32.22%$8.42M-$30.75M(m)$14.84M$100.34M$87.00K
2022-12-31Reported-$17.2M(m)(m)(m)-15.27%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$17.69M(m)(m)(m)-17.03%$6.33M*$3.67M*(m)$11.45M$80.56M$116.00K
2022-06-30Reported-$20.05M(m)(m)(m)-19.65%$10.83M*-$372.00K*(m)$11.95M$81.75M$33.00K
2022-03-31Reported-$45.45M(m)(m)(m)-49.20%$5.57M-$38.88M(m)$10.54M$73.16M$47.00K
2021-09-30Reported(m)-$23.28M(m)$85.43M(m)$13.31M*$17.68M*(m)$8.69M$70.75M$94.00K
2021-06-30Reported(m)-$16.99M(m)$81.28M(m)$5.92M*-$543.00K*(m)$9.61M$62.67M$116.00K
2021-03-31Reported(m)-$27.47M(m)$74.31M(m)$4.21M-$41.84M(m)$8.51M$69.81M$98.00K
2020-09-30Reported(m)-$4.76M(m)$71.94M(m)$5.60M*$10.94M*(m)$8.77M$49.70M$105.00K
2020-06-30Reported(m)-$20.16M(m)$50.88M(m)$2.18M*-$10.15M*(m)$12.54M$43.01M$131.00K
2020-03-31Reported(m)-$9.17M(m)$63.53M(m)$3.40M-$22.37M(m)$8.41M$48.23M$17.00K
2019-09-30Reported(m)-$18.26M(m)$54.67M(m)$3.36M*-$861.00K*(m)$13.50M$45.65M$20.00K
2019-06-30Reported(m)-$10.56M(m)$52.44M(m)$3.57M*$1.02M*(m)$7.83M$42.16M$15.00K
2019-03-31Reported(m)-$8.20M(m)$48.33M(m)$1.71M-$17.16M(m)$6.70M$38.07M$12.00K
2018-09-30Reported(m)-$9.22M(m)$38.44M(m)$1.46M*-$5.10M*(m)$5.09M$32.62M$0.00
2018-06-30Reported(m)-$12.78M(m)$35.29M(m)$1.12M*-$6.36M*(m)$4.65M$33.94M$0.00
2018-03-31Reported(m)-$10.60M(m)$31.76M(m)$1.11M-$13.26M(m)$4.04M$29.77M$0.00
2017-09-30Reported(m)-$5.98M(m)$25.04M(m)$531.00K*-$3.79M*(m)$3.79M$20.31M$0.00
2017-06-30Reported(m)-$5.92M(m)$23.85M(m)$946.00K*(m)(m)$2.78M$20.25M$0.00*
2017-03-31Reported(m)-$4.75M(m)$21.44M(m)$1.17M(m)(m)$2.62M$17.22M$0.00
2016-09-30Reported(m)-$2.67M(m)(m)(m)$752.00K*(m)(m)$1.64M$12.53M$0.00
2016-06-30Reported(m)-$3.70M(m)(m)(m)$410.00K*(m)(m)$1.67M$12.61M$0.00*
2016-03-31Reported(m)-$4.87M(m)(m)(m)$659.00K(m)(m)$1.54M$11.52M$0.00
2015-09-30Reported(m)-$5.50M(m)(m)(m)(m)(m)(m)$1.65M$9.45M(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$36.71M(m)(m)(m)-4.91%$46.34M$80.86M(m)(m)$492.55M$953.00K
2024-12-31Reported-$94.81M(m)(m)(m)-16.02%$33.94M$3.39M(m)(m)$418.56M$565.00K
2023-12-31Reported-$108.86M(m)(m)(m)-22.10%$40.42M-$50.10M(m)$60.24M$385.64M$750.00K
2022-12-31Reported-$100.38M(m)(m)(m)-24.43%$29.83M-$23.01M(m)$46.61M$322.20M$269.00K
2021-12-31Reported-$90.14M(m)(m)(m)-27.92%$28.07M-$37.75M(m)$38.67M$274.84M$367.00K
2020-12-31Reported-$36.77M(m)(m)(m)-13.87%$13.55M-$13.76M(m)$41.33M$197.23M$229.00K
2019-12-31Reported(m)-$54.76M(m)$214.55M(m)$20.46M-$21.86M(m)$37.30M$179.52M$65.00K
2018-12-31Reported(m)-$45.69M(m)$147.28M(m)$5.18M-$29.09M(m)$20.86M$133.31M$44.00K
2017-12-31Reported(m)-$27.59M(m)$99.13M(m)$3.56M-$14.91M(m)$13.27M$85.25M$0.00
2016-12-31Reported(m)-$15.58M(m)$64.07M(m)$2.76M-$16.65M(m)$7.15M$51.62M$0.00
2015-12-31Reported(m)-$21.63M(m)(m)(m)$1.79M(m)(m)$6.35M$36.72M$0.00
2014-12-31Reported(m)-$14.77M(m)(m)(m)$539.00K(m)(m)$5.70M$20.23M$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
AtriCure, Inc. (ATRC)United States$3.089B
Heartflow, Inc. (HTFL)United States$4.225B
HAEMONETICS CORP (HAE)United States$4.821B36.52
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87